5,377 Shares in SPDR S&P Biotech ETF $XBI Purchased by Blue Edge Capital LLC

Blue Edge Capital LLC bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the second quarter, HoldingsChannel reports. The fund bought 5,377 shares of the exchange traded fund’s stock, valued at approximately $851,000.

Several other hedge funds and other institutional investors have also bought and sold shares of XBI. Bank of America Corp DE raised its holdings in shares of SPDR S&P Biotech ETF by 13.3% during the first quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock valued at $1,854,388,000 after purchasing an additional 1,700,851 shares during the last quarter. Morgan Stanley boosted its holdings in SPDR S&P Biotech ETF by 8.3% in the fourth quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock worth $1,401,181,000 after purchasing an additional 882,718 shares during the last quarter. Wells Fargo & Company MN grew its position in SPDR S&P Biotech ETF by 75.7% in the 4th quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock worth $434,835,000 after purchasing an additional 1,536,122 shares during the period. Avoro Capital Advisors LLC purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at $256,053,000. Finally, Bessemer Group Inc. raised its stake in SPDR S&P Biotech ETF by 13.5% during the 4th quarter. Bessemer Group Inc. now owns 1,853,232 shares of the exchange traded fund’s stock valued at $225,965,000 after buying an additional 220,244 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

NYSEARCA XBI opened at $168.23 on Friday. The stock has a market capitalization of $10.99 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a 1-year low of $89.33 and a 1-year high of $169.89. The business’s fifty day moving average price is $156.35 and its 200-day moving average price is $138.96.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.